Zobrazeno 1 - 10
of 157
pro vyhledávání: '"Hisayoshi Suma"'
Autor:
Hisayoshi Suma
Publikováno v:
Korean Journal of Thoracic and Cardiovascular Surgery, Vol 49, Iss 4, Pp 225-231 (2016)
Throughout its 30-year history, the right gastroepiploic artery (GEA) has been useful for in situ grafts in coronary artery bypass grafting (CABG). The early graft patency rate is high, and the late patency rate has improved by using the skeletoniz
Externí odkaz:
https://doaj.org/article/e8532161fc0c47a9b73307864351c7de
Autor:
Hisayoshi Suma
Publikováno v:
Cirugía Cardiovascular, Vol 15, Iss 3, Pp 243-248 (2008)
Externí odkaz:
https://doaj.org/article/724a5024c9d34097bf46e6df4535312a
Autor:
Hiroshi Sohara, MD, Shutaro Satake, MD, Kazushi Tanaka, MD, Shigeru Saito, MD FACC, Hiroshi Domae, MD, Saeko Takahashi, MD, Yoshio Taketani, MD, Takaaki Shiono, MD, Yusuke Miyashita, MD, Shinji Tanaka, MD, Yoshio Watanabe, MD FACC FAHA, Hideki Ueno, MD, Hisayoshi Suma, MD, Masato Murakami, MD, Sugako Ishigaki, MD, Nobuyuki Takasu, MD, Yoshio Yamaguchi, MD, Noboru Takekoshi, MD
Publikováno v:
Journal of Arrhythmia, Vol 21, Iss 3, Pp 384-397 (2005)
Objective: The purpose of this study was to provide detailed information as to the modification of electrophysiological properties of pulmonary veins (PVs) and adjacent left atrial (LA) tissue caused by circumferential ablation (ABL) of superior and
Externí odkaz:
https://doaj.org/article/9d8759e79ab14ba0a1fd4f5952dc06ed
The right gastroepiploic artery (RGEA) conduit is the only other in situ arterial graft available for use in coronary artery bypass graft surgery other than the internal thoracic artery. Total arterial revascularization using only pedicled grafts can
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3b9dca001b9f5777052932794b7a46a5
https://doi.org/10.1093/med/9780198758785.003.0047
https://doi.org/10.1093/med/9780198758785.003.0047
Autor:
Karla V. Ballman, Fabio Barili, Piroze M. Davierwala, Thomas A. Schwann, Steven Goldman, Robert F. Tranbaugh, David P. Taggart, Peter Kappetein, Domenico Pagano, Mario Gaudino, Roberto Lorusso, John H. Alexander, Marc Ruel, Hisayoshi Suma, Stephen E. Fremes, Antonio M. Calafiore, Darren Mylotte, Faisal G. Bakaeen
Publikováno v:
European Journal of Cardio-thoracic Surgery, 52(6), 1031-1040. Elsevier
European Journal of Cardio-Thoracic Surgery, 52(6), 1031-1040. Oxford University Press
European Journal of Cardio-Thoracic Surgery, 52(6), 1031-1040. Oxford University Press
Summary The primary hypothesis of the ROMA trial is that in patients undergoing primary isolated non-emergent coronary artery bypass grafting, the use of 2 or more arterial grafts compared with a single arterial graft (SAG) is associated with a reduc
Autor:
Hisayoshi Suma, Anelechi C. Anyanwu
Publikováno v:
Seminars in Thoracic and Cardiovascular Surgery. 24:294-301
Over the past 3 decades, several observational studies established a role for surgical ventricular restoration (SVR) in the treatment of ischemic cardiomyopathy. In 2009, the Surgical Treatment for Ischemic Heart Failure (STICH) trial reported their
Autor:
Hisayoshi, Suma
Publikováno v:
Nihon rinsho. Japanese journal of clinical medicine. 74
Publikováno v:
European Journal of Cardio-Thoracic Surgery. 36:280-285
Objective:A poorfunctioningdilatedleftventriclewithmitralregurgitation istheworstconditioninchronicischemic heartfailure.Our7-year experience in combined mitral valve and left ventricular reconstruction was evaluated. Materials and methods: Among 246
Autor:
Hisayoshi Suma
Publikováno v:
Circulation Journal. 73:A19-A22
Batista introduced the partial left ventriculectomy (PLV), which is based on physics alone. With experience, it has been found that the extent of myocardial disease and viability of retained muscle is an important determinant of early and late surviv
Autor:
Yasuharu Ogura, Tadashi Isomura, Yasushi Kitaura, Hisayoshi Suma, Hiroaki Shimomura, Taiko Horii, Yoshinobu Eishi, Kaoru Otsuka, Fumio Terasaki
Publikováno v:
Circulation Journal. 71:1937-1941
Background Cardiac sarcoidosis is frequently overlooked or misdiagnosed as idiopathic dilated cardiomyopathy (DCM), primarily because of difficulties in its diagnosis. This is a crucial issue because appropriate therapy with immunosuppressive agents